- Home
- ASGN vs APLS Comparison
ASGN vs APLS Comparison
Compare ASGN & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- APLS
- Stock Information
- Founded
- ASGN 1985
- APLS 2009
- Country
- ASGN United States
- APLS United States
- Employees
- ASGN N/A
- APLS N/A
- Industry
- ASGN Professional Services
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- ASGN Consumer Discretionary
- APLS Health Care
- Exchange
- ASGN Nasdaq
- APLS Nasdaq
- Market Cap
- ASGN 4.2B
- APLS 3.6B
- IPO Year
- ASGN 1992
- APLS 2017
- Fundamental
- Price
- ASGN $67.48
- APLS $27.52
- Analyst Decision
- ASGN Buy
- APLS Buy
- Analyst Count
- ASGN 4
- APLS 18
- Target Price
- ASGN $101.75
- APLS $46.71
- AVG Volume (30 Days)
- ASGN 516.1K
- APLS 1.4M
- Earning Date
- ASGN 02-05-2025
- APLS 02-28-2025
- Dividend Yield
- ASGN N/A
- APLS N/A
- EPS Growth
- ASGN N/A
- APLS N/A
- EPS
- ASGN 3.83
- APLS N/A
- Revenue
- ASGN $4,099,700,000.00
- APLS $715,216,000.00
- Revenue This Year
- ASGN $4.15
- APLS $97.25
- Revenue Next Year
- ASGN $7.70
- APLS $12.68
- P/E Ratio
- ASGN $17.62
- APLS N/A
- Revenue Growth
- ASGN N/A
- APLS 162.10
- 52 Week Low
- ASGN $67.01
- APLS $24.34
- 52 Week High
- ASGN $106.42
- APLS $71.90
- Technical
- Relative Strength Index (RSI)
- ASGN 17.20
- APLS 38.99
- Support Level
- ASGN $78.69
- APLS $26.84
- Resistance Level
- ASGN $81.62
- APLS $28.59
- Average True Range (ATR)
- ASGN 2.79
- APLS 1.12
- MACD
- ASGN -1.65
- APLS -0.03
- Stochastic Oscillator
- ASGN 2.20
- APLS 18.09
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.